Kura Oncology, Inc.
KURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$74,116 | -$66,122 | -$57,429 | -$19,217 |
| Dep. & Amort. | $164 | $224 | $241 | $204 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10,965 | $6,949 | $7,842 | $8,631 |
| Change in WC | -$44,237 | $35,860 | -$20,052 | $282,258 |
| Other Non-Cash | $26,597 | -$5,688 | -$2,529 | -$2,745 |
| Operating Cash Flow | -$80,627 | -$28,777 | -$71,927 | $269,131 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,567 | -$1,458 | -$292 | -$372 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$268,714 | -$240,583 |
| Inv. Sales/Matur. | $0 | $0 | $167,597 | $146,000 |
| Other Inv. Act. | $96,533 | $60,399 | $0 | $0 |
| Investing Cash Flow | $93,966 | $58,941 | -$101,409 | -$94,955 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $143 | -$1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $515 | $0 | $807 |
| Financing Cash Flow | $0 | $515 | $143 | $806 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $13,339 | $30,679 | -$173,193 | $174,982 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81,948 | $51,269 | $224,462 | $49,480 |
| End Cash | $95,287 | $81,948 | $51,269 | $224,462 |
| Free Cash Flow | -$83,194 | -$30,235 | -$72,219 | $268,759 |